Log in

ETR:RHKRhoen Klinikum Stock Price, Forecast & News

€18.14
+0.70 (+4.01 %)
(As of 07/8/2020 04:01 AM ET)
Add
Compare
Today's Range
€17.40
Now: €18.14
€18.19
50-Day Range
€17.44
MA: €18.14
€18.42
52-Week Range
€14.14
Now: €18.14
€27.40
Volume52,074 shs
Average Volume43,281 shs
Market Capitalization$1.21 billion
P/E Ratio30.23
Dividend Yield1.60%
BetaN/A
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany. Its hospitals offer treatment services primarily in the areas of cardiovascular, neurology, oncology, pulmonology, orthopedic, accident surgery; rehabilitation and nursing services to the elderly; and thoracic, tumors, and psychosomatic, as well as spinal, column, and joints diseases. As of December 31, 2018, it operated 11 hospitals and 5,369 beds/places at 5 medical sites. The company is headquartered in Bad Neustadt an der Saale, Germany.
Read More
Rhoen Klinikum logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.8Community Rank: 2.0Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.88 out of 5 stars


Industry, Sector and Symbol

Industry Medical Care
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+49-9-771650

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.49 billion
Cash Flow€4.31 per share
Book Value€17.29 per share

Profitability

Miscellaneous

Employees9,384
Market Cap$1.21 billion
Next Earnings Date8/6/2020 (Estimated)
OptionableNot Optionable

Receive RHK News and Ratings via Email

Sign-up to receive the latest news and ratings for RHK and its competitors with MarketBeat's FREE daily newsletter.

Rhoen Klinikum (ETR:RHK) Frequently Asked Questions

How has Rhoen Klinikum's stock been impacted by COVID-19 (Coronavirus)?

Rhoen Klinikum's stock was trading at €18.04 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, RHK shares have increased by 0.6% and is now trading at €18.14. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Rhoen Klinikum?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rhoen Klinikum in the last year. There are currently 2 sell ratings and 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Rhoen Klinikum.

When is Rhoen Klinikum's next earnings date?

Rhoen Klinikum is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020. View our earnings forecast for Rhoen Klinikum.

What price target have analysts set for RHK?

4 brokers have issued 12-month price objectives for Rhoen Klinikum's stock. Their forecasts range from €16.50 to €18.00. On average, they expect Rhoen Klinikum's stock price to reach €17.63 in the next year. This suggests that the stock has a possible downside of 2.8%. View analysts' price targets for Rhoen Klinikum.

Has Rhoen Klinikum been receiving favorable news coverage?

Media coverage about RHK stock has been trending negative on Wednesday, InfoTrie reports. InfoTrie rates the sentiment of news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Rhoen Klinikum earned a coverage optimism score of -2.1 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near term. View the latest news about Rhoen Klinikum.

Who are some of Rhoen Klinikum's key competitors?

What other stocks do shareholders of Rhoen Klinikum own?

Who are Rhoen Klinikum's key executives?

Rhoen Klinikum's management team includes the following people:
  • Mr. Stephan Holzinger, Chairman of Board of Management & CEO
  • Prof. Bernd Griewing, Chief Medical Officer & Member of Board of Management
  • Dr. Gunther Karl Weiß, COO & Member of Management Board (Age 53)
  • Mr. Jörg Demmler, Head of Technical Controlling & Environment (Age 67)
  • Julian Schmitt, Head of Investor Relation

What is Rhoen Klinikum's stock symbol?

Rhoen Klinikum trades on the ETR under the ticker symbol "RHK."

What is Rhoen Klinikum's stock price today?

One share of RHK stock can currently be purchased for approximately €18.14.

How big of a company is Rhoen Klinikum?

Rhoen Klinikum has a market capitalization of $1.21 billion and generates $1.49 billion in revenue each year. Rhoen Klinikum employs 9,384 workers across the globe.

What is Rhoen Klinikum's official website?

The official website for Rhoen Klinikum is www.rhoen-klinikum-ag.com.

How can I contact Rhoen Klinikum?

Rhoen Klinikum's mailing address is Schlossplatz 1, BAD NEUSTADT AN DER SAALE, 97616, Germany. The company can be reached via phone at +49-9-771650.

This page was last updated on 7/8/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.